Last updated 2026-07-20
- Raised Seed round led by XT Group, Aug 2025
Total raised
—
Last: Undisclosed Round 2025-09
Stage
Seed
Founded
2021
Headcount
6
HQ
Yavne, Israel
Sector
Health Tech & Life Sciences
About
Cellergy Therapeutics is an Israeli biotechnology company focused on developing first-in-class mitochondrial transplantation therapies. The company aims to restore cellular energy and rejuvenate function by producing intact and functional mitochondria for systemic, repeated administration, addressing major systemic indications such as CNS disorders, muscle degeneration, and aging.
Funding history · 1 round · — total
2025-08
Seed
Undisclosed
★ XT Group★ Fresh Fund
Headcount over time
From 8 (2025-10) to 12 (2026-03) · +4 (+50%) · 3 points · source: Finder history + radar grounding
Q&A
- What is Cellergy Therapeutics' primary focus?
- Cellergy Therapeutics focuses on mitochondrial transplantation therapy, aiming to treat degenerative and metabolic diseases by replacing compromised mitochondria with functional ones to restore cellular energy and enhance cell function.
- When was Cellergy Therapeutics founded?
- Cellergy Therapeutics was founded in May 2021.
- What is Cellergy Therapeutics' current employee count?
- Cellergy Therapeutics has 1-10 employees.
- Which investors participated in Cellergy Therapeutics' funding round in September 2025?
- In September 2025, XT Group and Fresh Fund participated in a funding round for Cellergy Therapeutics.
- What is the primary sector of Cellergy Therapeutics?
- Cellergy Therapeutics' primary sector is Health Tech & Life Sciences.
- Where is Cellergy Therapeutics headquartered?
- Cellergy Therapeutics is headquartered in Yavne, Israel.
- What is Cellergy Therapeutics' current product stage?
- Cellergy Therapeutics is currently in the R&D product stage.
Team · 2
Rachel Diamant
Founder · Co-founder and CEO
David Baram
Founder · Co-founder and Chairman of the board
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical Biotechnology
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnology
Business model
B2B
Tags
anti-agingmetabolic-diseasediabetescell-therapycns-disordersregenerative-medicinetype-2-diabetes
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | cellergy-bio.com/ |
|---|---|
| linkedin.com/company/106252264 |
Identifiers & details
| Legal name | Cellergy Therapeutics Ltd. |
|---|---|
| Founded | 2021-5 |
| Employees (exact) | 6 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | cellergy-bio.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516400835 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2021-05-24 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 1 |
| Registry events | 10 — shares_capital (5), charge (1), violation (1), people (1), other (2) |
| Registered address | הקישון 18 יבנה |
Recent registry events
| Date | Event |
|---|---|
| 2025-11-25 | שינוי בהרכב הון - מניות-הפחתת הון מוקצה |
| 2026-05-24 | רישום שעבוד |
| 2026-06-22 | עדכון הפרה |
| 2025-08-11 | עדכון דירקטורים-הוספת דירקטור |
| 2025-08-10 | שינוי בהרכב הון - מניות-פיצול מניה |
| 2025-08-10 | שינוי בתקנון |
| 2025-08-07 | הגדלה של הון רשום |
| 2025-08-07 | עדכון כתובת ו/או מען דיגיטלי |
| 2025-12-02 | הקצאת מניות |
| 2025-12-01 | העברת מניות |